Home

BCR is a pioneer in diagnostic testing with two innovative products ready for licensing:

  • FiBIR™ (named for Fiber-based Internal Reflection)

News
May 4, 2016
Category: General
Posted by: boris123

 

Chandler, Arizona, May 4, 2016.

        Taking sterility testing to higher levels, BCR Corp. announced FDA’s clearance of BCR-30-min BI™, a remarkably simple and rapid Biological Indicator (BI) containing spores of heat-resistant bacteria.

        The BCR-30-min BI™ is the first BI that perfectly matches CDC’s definition of an ideal monitoring system:

CDC, Dec. 2009.       “An ideal biological monitor of the sterilization process should be easy to use, be inexpensive, not be subject to exogenous contamination, provide positive results as soon as possible after the cycle so that corrective action may be accomplished, and provide positive results only when the sterilization parameters (e.g., steam-time and temperature, and/or saturated steam; ETO-time, temperature, relative humidity and/or ETO concentration) are inadequate to kill microbial contaminates.”



Oct 29, 2014
Category: General
Posted by: boris123

Simple Technology Could Reduce Cost of Fluorescence-based Instrumentation by More than Five-fold


Jan 14, 2011
Category: General
Posted by: boris123

BCR Diagnostics relocates to Chandler, Arizona

Nov 8, 2010
Category: General
Posted by: boris123

BCR Diagnostics awarded $204,630 grant under Qualifying Therapeutic Discovery Project (QTDP) program

Jun 16, 2006
Category: General
Posted by: boris123

BCR Corporation Presents An Innovative Breakthrough Biosensor Platform at National Institutes of Health "Life Sciences Showcase"